Patent · US Active

Drug composition and coating

US11529441B2 · kind B2 · utility

0Cited by
12References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2020
Grant dateDec 20, 2022
Priority date
Expiry dateJan 3, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2420/06
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

According to the invention there is provided inter alia a medical device for delivering a paclitaxel to a tissue, the device the device having a coating layer applied to a surface of the device, the coating layer comprising components i), ii) and iii), whereincomponent i) is a therapeutic agent which is paclitaxel; andcomponent ii) is urea or a pharmaceutically acceptable salt thereof, or a urea derivative or a pharmaceutically acceptable salt thereof; andcomponent iii) is succinic acid, glutaric acid or caffeine, or a pharmaceutically acceptable salt of any one thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.